Peter Juergensen, PA
Physician Assistant · New Haven, CTNPI 1982699799
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $5,850 of the $9,112 with a category attached, or 64.2%. Vifor Pharma, Inc. accounts for 65.1% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2021 at $6,091 and has fallen 85.8% since, to $864 in 2025. Among physician assistant clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 134 payments — averaging $68.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vifor Pharma, Inc.$6K
- Amgen$1K
- Travere Therapeutics, Inc.$300
- Akebia Therapeutics Inc$263
- Fresenius USA Marketing, Inc.$198
- Novo Nordisk$177
- plus $1K from 16 others
What the payments were for
- Speaking & faculty fees$5,85064%
- Travel & lodging$90%
- Food & beverage$3,22635%
- Education$270%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vifor Pharma, Inc. | 17 | $5,936 |
| Amgen | 23 | $1,045 |
| Travere Therapeutics, Inc. | 15 | $300 |
| Akebia Therapeutics Inc | 11 | $263 |
| Fresenius USA Marketing, Inc. | 9 | $198 |
| Novo Nordisk | 7 | $177 |
| Ardelyx, Inc. | 8 | $172 |
| AstraZeneca | 6 | $155 |
| Otsuka America Pharmaceutical, Inc. | 6 | $148 |
| Aurinia Pharma U.S., Inc. | 6 | $138 |
| Bayer | 4 | $100 |
| Mallinckrodt Hospital Products Inc. | 3 | $87 |
| Sanofi | 3 | $73 |
| Xeris Pharmaceuticals, Inc. | 4 | $71 |
| GSK | 3 | $55 |
| Ultragenyx Pharmaceutical Inc. | 2 | $38 |
| Calliditas Therapeutics US Inc. | 2 | $36 |
| Apellis Pharmaceuticals, Inc. | 1 | $33 |
| Lilly USA, LLC | 1 | $24 |
| Kyowa Kirin, Inc. | 1 | $23 |
| Boehringer Ingelheim | 1 | $21 |
| Alnylam Pharmaceuticals Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,112 in reported general payments places this provider in the 95th percentile of 1,795 physician assistant providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 16 | $22,193 |
| LokelmaSodium Zirconium Cyclosilicate | 26 | $19,134 |
| Sevelamer Carbonate | 37 | $3,758 |
| Potassium Citrate ErPotassium Citrate | 11 | $2,297 |
| Losartan Potassium | 31 | $454 |
| Amlodipine Besylate | 35 | $250 |
| Allopurinol | 26 | $246 |
| Valsartan | 13 | $210 |
| Metoprolol Succinate | 16 | $171 |
| Carvedilol | 25 | $170 |
| Furosemide | 19 | $149 |
| Clonidine Hcl | 15 | $70 |
| Atorvastatin Calcium | 15 | $66 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Lokelma | $155 | $41,32742 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,795 physician assistant providers in Connecticut.
Other physician assistant in New Haven
- Michael LalondeNew Haven$35K
- Kathryn MidgleyNew Haven$28K
- Rachel MarineNew Haven$13K
- Gary SpinnerBridgeport$119K
- Jordan MarcouTrumbull$44K
- Mary ElliottGuilford$43K
- Christopher ThompsonGroton$42K
- Kristine LaneMiddletown$30K
- Richard MoroPlainfield$25K
- Janine TedescoDarien$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.